Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 8.201M
March 31, 2026 4.161M
December 31, 2025 6.151M
September 30, 2025 8.232M
June 30, 2025 9.743M
March 31, 2025 11.54M
December 31, 2024 6.879M
September 30, 2024 7.494M
June 30, 2024 9.341M
March 31, 2024 7.833M
December 31, 2023 8.815M
September 30, 2023 10.51M
June 30, 2023 9.951M
March 31, 2023 11.87M
December 31, 2022 5.122M
September 30, 2022 8.611M
June 30, 2022 11.22M
March 31, 2022 7.884M
Date Value
December 31, 2021 9.882M
September 30, 2021 13.35M
June 30, 2021 16.57M
March 31, 2021 19.95M
December 31, 2020 4.646M
September 30, 2020 5.377M
June 30, 2020 6.836M
March 31, 2020 4.824M
December 31, 2019 2.396M
September 30, 2019 4.309M
June 30, 2019 4.188M
March 31, 2019 5.368M
December 31, 2018 0.155M
September 30, 2018 0.7343M
June 30, 2018
March 31, 2018
December 31, 2017 1.184M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B

Shareholders Equity (Quarterly) Related Metrics